News
Filter
-
Organon and MRC Technology sign antibody development agreement
Read more: Organon and MRC Technology sign antibody development agreement -
MRCT to humanize antibody to treat SLE
Read more: MRCT to humanize antibody to treat SLE -
MRCT to humanize antibody to treat AD
Read more: MRCT to humanize antibody to treat AD -
TYSABRI gains market approval
Read more: TYSABRI gains market approval -
MRCT and Chinese National Centre collaborate on malaria
Read more: MRCT and Chinese National Centre collaborate on malaria -
Therapeutic Antibody Group starts
Read more: Therapeutic Antibody Group starts -
MRC to receive over USD200m
Read more: MRC to receive over USD200m